Bone marrow stromal cell antigen 2 is a novel therapeutic target of glioblastoma stem cells
Ontology highlight
ABSTRACT: we identified BST-2 is a novel therapeutic target and BST-2 depletion leads to downregulated CSC-related signaling molecules.
ORGANISM(S): Homo sapiens
PROVIDER: GSE85024 | GEO | 2018/08/01
REPOSITORIES: GEO
ACCESS DATA